Jafron Hemoadsorption cartridges for Chronic Conditions

Product description

Chronic conditions require treatment solutions that go beyond standard blood purification alone. Jafron hemoadsorption cartridges provide a valuable adjunct by selectively removing harmful substances from the blood or plasma, thereby supporting existing therapies.¹

Within this portfolio, different cartridges are available for a range of applications in chronic care. Depending on the clinical need, they may be used for, among other things, the removal of uremic toxins in kidney-related conditions, the adsorption of bilirubin and bile acids in liver-related disorders, and the reduction of specific immune factors in immune-mediated conditions.

Targeted support across different indication areas
Each Jafron cartridge is developed with a specific treatment goal in mind. This makes it possible to tailor extracorporeal therapy more closely to the nature of the condition and the patient’s clinical situation.

Where conventional techniques are primarily aimed at general blood purification, Jafron hemoadsorption cartridges offer additional possibilities for the targeted removal of substances that are often more difficult to eliminate with standard methods.¹ This makes them a powerful complement within existing treatment pathways.

Technology focused on selective removal
The cartridges use adsorption technology, in which blood or plasma is passed extracorporeally through a cartridge containing adsorptive material. This material binds specific toxic or pathological components, allowing them to be effectively removed from the circulation.¹

Thanks to this targeted mode of action, adsorption cartridges can contribute to a more complete and goal-oriented extracorporeal treatment approach, suitable for a variety of applications in chronic conditions.

Broad applicability, aligned with clinical practice
Because different cartridges are available for different indication areas, a solution can be selected for each treatment that matches the intended therapeutic goal. In this way, these cartridges support healthcare professionals in the more targeted and flexible use of extracorporeal therapies in daily clinical practice.

View the full overview
The different Jafron cartridges within the chronic care application area are included in the product table at the bottom of this page. There you will find, in one clear overview, which solutions are available and for which indications they may be used.

Footnote
¹ Reis, T., Cantaluppi, V., Ostermann, M., Brendolan, A., Cai, G.-Y., Juillard, L., Meijers, B., Gomez, L., Nguyen, H. D., Ramírez-Guerrero, G., Floris, M., Chakravarthi, R., Małyszko, J., Petras, D., Bamihas, G., Ding, X., Ankawi, G., Cozzolino, M., Husain-Syed, F., ... Ronco, C. (2026). Hemoadsorption combined with hemodialysis (HAHD): A consensus statement from an international expert panel. Nephrology Dialysis Transplantation. Advance online publication. https://doi.org/10.1093/ndt/gfag046

Would you like to receive more information about this product, or request a quote? Klik hier!

Product information